Still SF [Two-Stage / GS Designs]

posted by VStus – Poland, 2016-10-11 09:10 (1401 d 14:07 ago) – Posting: # 16716
Views: 10,820

Hi Helmut,

» lucid words about SF and great ideas about hacking embeded Linux-machines. :-D

Well, it's a proven solution (not by me!), just not quite legal in most of civilized countries ;)

» In a TSD we have some chances to demonstrate BE already in the first stage. Hence, my personal recommendation for n1 75-80% of the fixed sample’s n.

After playing with data from other studies, I've made a suggestion that same recommendation is good single stage cross-over with 2 groups to keep the study safe or "conservative"... We can then demonstrate BE based on larger (first) group if requested by regulators.

Regards, VStus

Complete thread:

 Admin contact
21,008 posts in 4,379 threads, 1,460 registered users;
online 13 (0 registered, 13 guests [including 8 identified bots]).
Forum time: Wednesday 23:18 CEST (Europe/Vienna)

Statistics is the art of never having to say you’re wrong.
Variance is what any two statisticians are at.    C.J. Bradfield

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz